VERMOX
NDC 50458-675, mebendazole, tablet, chewable, from Janssen Pharmaceuticals, Inc..
- Product NDC
- 50458-675
- Status
- Listed
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208398
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50458-675 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEBENDAZOLE500 mg/1
Pharmacologic classes
Anthelmintic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50458-675-20 | 50458067520 | 200 TABLET, CHEWABLE in 1 BOTTLE (50458-675-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a720c424-517a-461b-8e13-6c37caf8aa3f
Use it
Look up 50458-675 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50458-675 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50458-675. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.